Jason K Myers

This inventor holds 11 USPTO granted patents. Top assignees: Pharmacia & Upjohn Company, Pfizer Corporation. Active years: 2002-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jason K Myers. Retrieved from https://idiyas.com/inventor/jason-k-myers

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11

% Patents Active = 9.1

Average Co-Inventor Count = 5.1

ph-index = 9

Forward Citations = 233(Granted Patents)

Company Filing History:

7 out of 523

Pharmacia & Upjohn Company

Years Active: 2002-2006

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7001900 - Azabicyclic compounds for the treatment of disease (2006-02-21),

2. 6919359 - Azabicyclic-substituted-heteroaryl compounds for the treatment of disease (2005-07-19),

3. 6869946 - Substituted azabicyclic moieties for the treatment of disease (2005-03-22),

4. 6852716 - Substituted-aryl compounds for treatment of disease (2005-02-08),

5. 6599916 - Quinuclidine-substituted heteroaryl moieties for treatment of disease (2003-07-29),

6. 6562816 - Substituted-heteroaryl-7-aza[2.2.1]bicycloheptanes for the treatment of disease (2003-05-13),

7. 6500840 - Quinuclidine-substituted heteroaryl moieties for treatment of disease (2002-12-31),

8. 6492386 - Quinuclidine-substituted aryl compounds for treatment of disease (2002-12-10),

9. 6492385 - Quinuclidine-substituted heteroaryl moieties for treatment of disease (2002-12-10),

10. 6486172 - Quinuclidine-substituted aryl compounds for treatment of disease (2002-11-26),

11. 6479510 - Quinuclidine-substituted aryl compounds for treatment of disease (2002-11-12),

Title: The Innovative Contributions of Jason K. Myers

Introduction

Jason K. Myers is a prominent inventor based in Kalamazoo, MI (US), known for his significant contributions to the field of pharmaceuticals. With a total of 11 patents to his name, Myers has made remarkable strides in developing compounds that have the potential to treat various diseases.

Latest Patents

Among his latest patents, Myers has developed azabicyclic compounds for the treatment of disease. These compounds are characterized by a six-membered heterocyclic ring system that contains 1–2 nitrogen atoms or a 10-membered bicyclic-six-six-fused-ring system with up to two nitrogen atoms. The invention also includes pharmaceutical salts or compositions that may be in pure enantiomeric form or racemic mixtures, which are useful in treating diseases where α7 is known to be involved. Another notable patent involves azabicyclic-substituted-heteroaryl compounds, which also serve a similar purpose in pharmaceuticals.

Career Highlights

Throughout his career, Jason K. Myers has worked with esteemed companies such as Pharmacia & Upjohn Company and Pfizer Corporation. His experience in these organizations has greatly contributed to his expertise in pharmaceutical innovations.

Collaborations

Myers has collaborated with notable colleagues, including Vincent E. Groppi, Jr. and David W. Piotrowski. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the pharmaceutical industry.

Conclusion

Jason K. Myers exemplifies the spirit of innovation in the pharmaceutical field through his extensive patent portfolio and collaborative efforts. His work continues to pave the way for advancements in treatments for various diseases.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]